Skip to main content
RxCopaysGet started

IROSPAN 24/6

Generic: IRON, FOLIC ACID, VITAMIN/MINERAL SUPPLEMENT

Verified·Apr 23, 2026
Manufacturer
Mission Pharmacal
NDC
50967-126
RxCUI
1102196
ICD-10 indication
D50.9

Affordability Check

How much will you actually pay for IROSPAN 24/6?

In 30 seconds, see every legitimate way to afford IROSPAN 24/6 — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About IROSPAN 24/6

Irospan 24/6 is a prescription iron supplement indicated for the treatment of iron deficiency and iron deficiency anemia. The regimen consists of 24 active tablets containing 65 mg of elemental iron (derived from both carbonyl iron and ferrous sulfate), vitamin C (ascorbic acid), and succinic acid to enhance absorption, followed by 6 inert tablets to maintain daily dosing compliance.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

Cost Plus Drug Company

Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for IRON, FOLIC ACID, VITAMIN/MINERAL SUPPLEMENT.

Browse Cost Plus medications →

GoodRx

Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.

Lookup IROSPAN 24/6 →

NeedyMeds

Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.

Search for IRON, FOLIC ACID, VITAMIN/MINERAL SUPPLEMENT →

RxAssist

PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.

Search PAPs →

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for IROSPAN 24/6. Official source: DailyMed (NLM) · Label effective May 13, 2025

Boxed warning
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Indications and usage
INDICATION AND USAGE: IROSPAN 24/6 is indicated for the treatment of all anemias that are responsive to oral iron therapy. These include: hypochromic anemia associated with pregnancy, chronic and/or acute blood loss, metabolic disease, post-surgical convalescence, and dietary needs.
Dosage and administration
Dosage and Administration Usual adult dosage is 1 tablet daily or as directed by a physician. The IROSPAN® carton contains a 30 day course of iron therapy that consists of 24 light blue tablets and 6 white tablets. Take 1 light blue tablet daily for 24 days, followed by 1 white tablet daily for 6 days. After the 30 tablets have been taken, a new course may be started if prescribed.
Contraindications
Warnings: Ingestion of more than 3 grams of omega-fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis. Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
Adverse reactions
A dverse Reactions: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

———

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.